170 related articles for article (PubMed ID: 37347754)
1. Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina.
Ray EM; Teal RW; Carda-Auten J; Coffman E; Sanoff HK
PLoS One; 2023; 18(6):e0287338. PubMed ID: 37347754
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Healthcare professionals' perspectives on facilitators of and barriers to CKD management in primary care: a qualitative study in Singapore clinics.
Ramakrishnan C; Tan NC; Yoon S; Hwang SJ; Foo MWY; Paulpandi M; Gun SY; Lee JY; Chang ZY; Jafar TH
BMC Health Serv Res; 2022 Apr; 22(1):560. PubMed ID: 35473928
[TBL] [Abstract][Full Text] [Related]
4. A qualitative analysis of interprofessional healthcare team members' perceptions of patient barriers to healthcare engagement.
Powell RE; Doty A; Casten RJ; Rovner BW; Rising KL
BMC Health Serv Res; 2016 Sep; 16():493. PubMed ID: 27644704
[TBL] [Abstract][Full Text] [Related]
5. Barriers to and Facilitators of Oral Health Among Persons Living With Mental Illness: A Qualitative Study.
Wright WG; Averett PE; Benjamin J; Nowlin JP; Lee JGL; Anand V
Psychiatr Serv; 2021 Feb; 72(2):156-162. PubMed ID: 33234051
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective.
Masese RV; Bulgin D; Douglas C; Shah N; Tanabe P
PLoS One; 2019; 14(5):e0216414. PubMed ID: 31063506
[TBL] [Abstract][Full Text] [Related]
7. Primary Care Providers' Use of Genetic Services in the Southeast United States: Barriers, Facilitators, and Strategies.
Seibel E; Gunn G; Ali N; Jordan E; Kenneson A
J Prim Care Community Health; 2022; 13():21501319221134752. PubMed ID: 36345220
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to early-stage lung cancer care in the USA: a qualitative study.
Herb J; Friedman H; Shrestha S; Kent EE; Stitzenberg K; Haithcock B; Mody GN
Support Care Cancer; 2022 Dec; 31(1):21. PubMed ID: 36513843
[TBL] [Abstract][Full Text] [Related]
9. Health Care Needs, Experiences, and Perspectives of Autistic Adults.
Mazurek MO; Sadikova E; Cheak-Zamora N; Hardin A; Sohl K; Malow BA
Autism Adulthood; 2023 Mar; 5(1):51-62. PubMed ID: 36941853
[TBL] [Abstract][Full Text] [Related]
10. Decision-Making About Tracheostomy for Children With Medical Complexity: Caregiver and Health Care Provider Perspectives.
Gower WA; Golden SL; King NMP; Nageswaran S
Acad Pediatr; 2020; 20(8):1094-1100. PubMed ID: 32540425
[TBL] [Abstract][Full Text] [Related]
11. Multi-stakeholder perspectives on the implementation of a clinic-based food referral program for patients with chronic conditions: a qualitative examination.
DePuccio MJ; Garner JA; Hefner JL; Coovert N; Clark A; Walker DM
Transl Behav Med; 2022 Oct; 12(9):927-934. PubMed ID: 36205467
[TBL] [Abstract][Full Text] [Related]
12. Facilitators and barriers to post-discharge pain assessment and triage: a qualitative study of nurses' and patients' perspectives.
Chen J; Wijesundara JG; Patterson A; Cutrona SL; Aiello S; McManus DD; McKee MD; Wang B; Houston TK
BMC Health Serv Res; 2021 Sep; 21(1):1021. PubMed ID: 34583702
[TBL] [Abstract][Full Text] [Related]
13. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
[TBL] [Abstract][Full Text] [Related]
14. Clinician Perspectives on Palliative Care for People with Hepatocellular Carcinoma: Facilitators of and Barriers to Referral.
Woodrell CD; Mulholland CN; Goldstein NE; Hutchinson CL; Schiano TD; Hansen L
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509278
[TBL] [Abstract][Full Text] [Related]
15. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
Shea CM; Gertner AK; Green SL
Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
[TBL] [Abstract][Full Text] [Related]
16. Physical Activity Facilitators and Barriers Among Retired Women in North Carolina: A Qualitative Study.
Jones SA; Leeman J; Evenson KR
N C Med J; 2020; 81(5):284-292. PubMed ID: 32900886
[No Abstract] [Full Text] [Related]
17. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
18. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.
Beal EW; Owen M; McNamara M; McAlearney AS; Tsung A
J Gastrointest Cancer; 2023 Jun; 54(2):332-356. PubMed ID: 35879510
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
